Dr Salk Polio Research

Years after the presidency of Roosevelt, Dr. Salk researched for a polio vaccine. Jonas Salk, born on October 28, 1914 (Carter 29), pursued the study of poliomyelitis on June 16, 1950 (Carter 95). Later that summer, Salk applied for a research grant on July 12 (Carter 100) from the National Foundation of Infantile Paralysis, but he could not use the accepted reward for polio research until 1951 (Reis 50). Salk's first idea was to develop different testable vaccines and experiment them on multiple types of monkeys and chimpanzees (Kluger 134). To be able to test his theory, the grant gave Salk 17,000 monkeys for his procedures (Kluger 123). First, Salk deactivated polioviruses by using formaldehyde, and then, he injected the "killed" viruses
At 10:00 A.M. on April 12, the foundation announced that the vaccine was safe, as well as effective (Seavey, Smith, and Wagner 174), and at 5:30 P.M., the federal government of the United States agreed to give manufacture and distribution rights for the production of the vaccine (Seavey, Smith, and Wagner 175). The people of the world named the vaccine after Salk, which was the "Salk Vaccine" (Reis 67), and by 1959, there were, on average, less than 10,000 polio cases a year (Bruno 291). Even though Salk created a life-saving vaccine, he never obtained a Nobel Prize for his successful research (Reis 71). When June 23, 1995 approached, Jonas Salk lived his last day and died from a cardiovascular failure (Kluger 318). With trial after trial, the polio vaccine was finally discovered. Throughout his early years and into his political life, Franklin Delano Roosevelt overcame the limitations of his polio diagnosis, and as a result, the changes he made to the United States, as president, are still used today, but eventually he died too soon before Jonas Salk’s effective vaccine against poliomyelitis was